礼来(LLY)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

LLY 礼来

休市中 05-17 16:00:00 EDT

770.00

-1.12

-0.15%

盘后770.75

+0.75+0.10%

19:58 EDT

最高774.87	最低767.10	成交量167.03万
今开772.89	昨收771.12	日振幅1.01%
总市值7,321亿	流通市值7,300亿	总股本9.51亿
成交额12.87亿	换手率0.18%	流通股本9.48亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"LLY","market":"US","secType":"STK","nameCN":"礼来","latestPrice":770,"timestamp":1715976000000,"preClose":771.12,"halted":0,"volume":1670317,"hourTrading":{"tag":"盘后","latestPrice":770.75,"preClose":770,"latestTime":"19:58 EDT","volume":148216,"amount":114125522.9175,"timestamp":1715990295235},"delay":0,"floatShares":948000000,"shares":950766100,"eps":5.8,"marketStatus":"休市中","marketStatusCode":7,"change":-1.12,"latestTime":"05-17 16:00:00 EDT","open":772.89,"high":774.87,"low":767.1,"amount":1287000795.5893,"amplitude":0.010076,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":5.8,"exchange":"NYSE","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1716192000000},"adr":0,"listingDate":102488400000,"adjPreClose":771.12,"adrRate":0,"dividendRate":0.006091,"preHourTrading":{"tag":"盘前","latestPrice":770.63,"preClose":771.12,"latestTime":"09:29 EDT","volume":2191,"amount":1694225.9155499998,"timestamp":1715952599894},"postHourTrading":{"tag":"盘后","latestPrice":770.75,"preClose":770,"latestTime":"19:58 EDT","volume":148216,"amount":114125522.9175,"timestamp":1715990295235},"volumeRatio":0.7449144124151201},"requestUrl":"/m/hq/s/LLY/wiki","defaultTab":"wiki","newsList":[{"id":"2436992347","title":"诺和诺德、礼来之后，哪家跨国药企能在“减肥药”赛道杀出重围？","url":"https://stock-news.laohu8.com/highlight/detail?id=2436992347","media":"澎湃新闻","top":-1,"share":"https://www.laohu8.com/m/news/2436992347?lang=zh_cn&edition=full","pubTime":"2024-05-17 18:39","pubTimestamp":1715942340,"startTime":"0","endTime":"0","summary":"在诺和诺德、礼来凭借GLP-1减肥药大赚的同时，其他跨国药企巨头也在加快自己的步伐。近两年，GLP-1药物用于减重风靡全球，跨国药企诺和诺德、礼来已经凭借获批药物收入大增。诺和诺德、礼来无疑是当下GLP-1赛道公认的两大王者，哪家跨国药企又能在GLP-1赛道的第二梯队脱颖而出也是业内关注的焦点。作为全球跨国药企巨头，罗氏此前以流感、肿瘤等疾病领域的药物为外界所熟知。另一家跨国药企安进的GLP-1/GLP药物AMG 133即将进入三期临床。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240517184003877422bb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240517184003877422bb&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2436399934","title":"胰岛素周制剂时代开启！诺和诺德礼来再度领跑","url":"https://stock-news.laohu8.com/highlight/detail?id=2436399934","media":"第一财经","top":-1,"share":"https://www.laohu8.com/m/news/2436399934?lang=zh_cn&edition=full","pubTime":"2024-05-17 17:40","pubTimestamp":1715938800,"startTime":"0","endTime":"0","summary":"胰岛素周制剂时代已经开启。当地时间5月16日，礼来公司表示，在针对2型糖尿病患者的两项研究中，每周一次的胰岛素注射剂efsitora所显示的血糖降低效果与常用的每日制剂胰岛素一致。礼来最新的数据也意味着，礼来和诺和诺德的竞争将从GLP-1药物领域进一步拓展至胰岛素周制剂领域。陈海冰认为，胰岛素周制剂未来如果能进入临床，将会极大提升患者用药的便捷性和依从性，让更多患者获益。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405171742048b1217a2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405171742048b1217a2&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2436967739","title":"BUZZ-DB 称罗氏可能挑战肥胖症药物领导者礼来和诺和诺德","url":"https://stock-news.laohu8.com/highlight/detail?id=2436967739","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2436967739?lang=zh_cn&edition=full","pubTime":"2024-05-17 16:08","pubTimestamp":1715933286,"startTime":"0","endTime":"0","summary":"    5月17日 - ** 德意志银行将瑞士生物技术公司罗氏  的评级从 \"卖出 \"上调至 \"持有\"，原因是肥胖症药物的成功前景有所改善** 周四，罗氏新收购的药物CT-388的早期试验数据显示，经安慰剂调整后，体重减轻了18.8%。** 罗氏公司周四公布数据后， ，股价上涨 3.2%。** 礼来  周四股价下跌  2%，至771.12美元，而美国竞争对手安进  和维京治疗  分别下跌约1.3%和11%。** 罗氏公司在 12 月份以 27 亿美元的价格从 Carmot Therapeutics    收购了 CT-388  ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2436936745","title":"隔夜美股全复盘(5.17)| 中概涨势喜人，法拉第未来本周累涨34倍，瑞幸咖啡大涨12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2436936745","media":"格隆汇","top":-1,"share":"https://www.laohu8.com/m/news/2436936745?lang=zh_cn&edition=full","pubTime":"2024-05-17 07:40","pubTimestamp":1715902838,"startTime":"0","endTime":"0","summary":"中概涨势喜人，法拉第未来本周累涨34倍，瑞幸咖啡大涨12%","market":"sg","thumbnail":"https://img7.gelonghui.com/column/2/140.png","type":0,"news_type":0,"thumbnails":["https://img7.gelonghui.com/column/2/140.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/739513","is_publish_highlight":false,"gpt_icon":0},{"id":"1184886873","title":"减肥药概念股走低，罗氏公布GLP-1/GIP新药1期积极结果","url":"https://stock-news.laohu8.com/highlight/detail?id=1184886873","media":"老虎资讯综合","top":-1,"share":"https://www.laohu8.com/m/news/1184886873?lang=zh_cn&edition=full","pubTime":"2024-05-16 23:03","pubTimestamp":1715871835,"startTime":"0","endTime":"0","summary":"与安慰剂相比，健康肥胖成人每周皮下注射一次CT-388，持续24周，可显著减轻体重。","market":"us","thumbnail":"https://static.tigerbbs.com/ae54da404d800bfa939f31c042e7f20c","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/ae54da404d800bfa939f31c042e7f20c"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"gpt_icon":0},{"id":"2435069306","title":"BUZZ-罗氏公司报告肥胖症药物早期数据良好，减肥药生产商股价下跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2435069306","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2435069306?lang=zh_cn&edition=full","pubTime":"2024-05-16 22:34","pubTimestamp":1715870054,"startTime":"0","endTime":"0","summary":"    5月16日 - ** 由于瑞士竞争对手罗氏  报告其新收购的肥胖症候选药物的早期数据良好，美国减肥药生产商的股价下跌 ** 礼来  下跌1.3%，报776.8美元；安进  下跌1.2%，报312.87美元；Viking Therapeutics  下跌4%，报74.93美元。** 罗氏公司的候选药物 CT-388 在一项针对成人肥胖症患者的早期研究中显示，安慰剂调整后的体重减轻率为 18.8** BMO资本市场分析师Evan Seigerman说：\"鉴于CT-388显示的减重效果，我们预计LLY、AMGN和NVO的股价将受到轻微的负面影响。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2435769146","title":"礼来(LLY.US)超长效胰岛素三期临床成功","url":"https://stock-news.laohu8.com/highlight/detail?id=2435769146","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2435769146?lang=zh_cn&edition=full","pubTime":"2024-05-16 19:27","pubTimestamp":1715858876,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，5月16日，礼来(LLY.US)公布每周一针超长效胰岛素Insulin Efsitora Alfa治疗二型糖尿病两项三期临床QWINT-2、QWINT-4获得积极数据。据悉，QWINT-2中，研究达到非劣效于德谷胰岛素的主要终点，Efsitora治疗组HbA1c降低1.34%，德谷胰岛素组降低1.26%。QWINT-4中，研究达到非劣效于甘精胰岛素的主要终点，Efsitora治疗组HbA1c降低1.07%，甘精胰岛素治疗组HbA1c同样降低1.07%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1122183.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2435736456","title":"礼来公司的每周胰岛素在后期研究中取得成功","url":"https://stock-news.laohu8.com/highlight/detail?id=2435736456","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2435736456?lang=zh_cn&edition=full","pubTime":"2024-05-16 18:52","pubTimestamp":1715856745,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    路透5月16日 - 礼来  周四表示，其每周一次的胰岛素efsitora在对2型糖尿病患者进行评估的两项后期试验中达到了主要目标。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2435628338","title":"礼来中国与上海市东方医院达成临床研究战略合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2435628338","media":"界面","top":-1,"share":"https://www.laohu8.com/m/news/2435628338?lang=zh_cn&edition=full","pubTime":"2024-05-16 15:29","pubTimestamp":1715844557,"startTime":"0","endTime":"0","summary":"礼来中国官微消息，2024年5月10日，礼来中国宣布与上海市东方医院达成临床研究战略合作。双方将全面深化在肿瘤、代谢、阿尔茨海默病等领域合作，加快相关创新药物的临床研究进度，协力培养高素质的临床研究人才，推动创新药在中国上市的进程。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405161529177a5a2edd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405161529177a5a2edd&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"1133566555","title":"杜肯家族办公室第一季度增持了Natera、减持礼来等","url":"https://stock-news.laohu8.com/highlight/detail?id=1133566555","media":"老虎智能写手","top":-1,"share":"https://www.laohu8.com/m/news/1133566555?lang=zh_cn&edition=full","pubTime":"2024-05-16 09:11","pubTimestamp":1715821872,"startTime":"0","endTime":"0","summary":"据《华尔街新闻》编辑Joshua Fineman报道，著名对冲基金大亨斯坦利·德鲁肯米勒的家族办公室杜肯家族办公室在2024年第一季度新建了对Coherent Corp 的持股，持有250万股，对Kinder Morgan持有390万股，对$Meta Platforms$持有63.93万股，对Discover Financial持有64.5万股。根据13F申报文件，该家族办公室增持了Natera190万股，增持了Woodward55万股，Vistra Corp.增持了24.1万股，Flex增持了270万股，ZoomInfo增持了500万股。据报道，第一季度削减的持股包括Eli Lilly 34.1万股，Nvidia44.2万股，Seagate 67.7万股和Vertiv130万股。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"gpt_icon":0},{"id":"2435666100","title":"礼来上涨3.13%，报786.58美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2435666100","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2435666100?lang=zh_cn&edition=full","pubTime":"2024-05-16 03:55","pubTimestamp":1715802934,"startTime":"0","endTime":"0","summary":"5月16日，礼来(LLY)盘中上涨3.13%，截至03:55，报786.58美元/股，成交16.61亿美元。财务数据显示，截至2024年03月31日，礼来收入总额87.68亿美元，同比增长25.98%；归母净利润22.43亿美元，同比增长66.77%。大事提醒：5月14日，礼来获雅运股份上调目标价至840美元，最新评级Buy。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2024/05/16035540661211.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2435659155","title":"英国减肥药价格竞争加剧，Pharmacy2U降价促销","url":"https://stock-news.laohu8.com/highlight/detail?id=2435659155","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2435659155?lang=zh_cn&edition=full","pubTime":"2024-05-15 22:49","pubTimestamp":1715784559,"startTime":"0","endTime":"0","summary":"背景曾对减肥药进行降价销售的英国药品零售公司包括 Simple Online Pharmacy、Mayfair Weight Loss Clinic 和 London Slimming Clinic。数字 通过在线处方服务为 140 多万英国患者提供服务的 Pharmacy2U 将一个月用量的 Wegovy 入门套装的价格从之前的 169 英镑降至 129 英镑。Pharmacy2U 表示，该优惠仅限于 5 月 31 日，但它 \"正在不断审查其减肥服务的价格，并将在 6 月份再次确认价格\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2435529041","title":"礼来公司与销售 Mounjaro 和 Zepbound 仿冒品的水疗中心达成和解","url":"https://stock-news.laohu8.com/highlight/detail?id=2435529041","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2435529041?lang=zh_cn&edition=full","pubTime":"2024-05-15 05:46","pubTimestamp":1715723205,"startTime":"0","endTime":"0","summary":"    路透5月14日 - 礼来  周二表示，该公司已与一家medi spa达成和解协议，该medi spa曾销售假冒其流行的糖尿病药物Mounjaro和减肥治疗药物Zepbound。作为协议的一部分，Totality Medispa 公司将向礼来公司支付一笔款项，并将不再使用礼来品牌推广其任何产品。预计该 Medi spa 将采取多项纠正措施，包括获得和分销符合美国联邦法律规定生产的复方替扎帕肽产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2435493495","title":"阿尔戈斯咨询公司：维持Eli Lilly and Co(LLY.US)评级，由买入调整至买入评级, 目标价由770.00美元调整至840.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2435493495","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2435493495?lang=zh_cn&edition=full","pubTime":"2024-05-15 01:15","pubTimestamp":1715706915,"startTime":"0","endTime":"0","summary":"阿尔戈斯咨询公司：维持Eli Lilly and Co(LLY.US)评级，由买入调整至买入评级, 目标价由770.00美元调整至840.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405150115168b086a12&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405150115168b086a12&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2435584028","title":"小摩：Q1增持逾1800万股苹果，减持Uber、礼来","url":"https://stock-news.laohu8.com/highlight/detail?id=2435584028","media":"格隆汇","top":-1,"share":"https://www.laohu8.com/m/news/2435584028?lang=zh_cn&edition=full","pubTime":"2024-05-14 07:49","pubTimestamp":1715644141,"startTime":"0","endTime":"0","summary":"摩根大通提交的13F美股持仓文件显示，一季度其增持逾1800万股苹果股票，持仓占比为2.27%；并增持了微软、英伟达、Meta Platforms、谷歌等明星科技股。此外，小摩还增持了瑞银、Stellantis、埃克森美孚石油(XOM.US)等明星股、减持美国银行、Uber(UBER.US)、礼来等。摩根大通截止3月底的持仓总规模为1.18万亿美元，较上季度增加0.14万亿美元。\n\n\r\n            责任编辑：栎树","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2024/05/14074940630677.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2435371041","title":"更新 2-由于需求增加，丹麦面临 Wegovy 短缺的问题","url":"https://stock-news.laohu8.com/highlight/detail?id=2435371041","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2435371041?lang=zh_cn&edition=full","pubTime":"2024-05-13 23:04","pubTimestamp":1715612642,"startTime":"0","endTime":"0","summary":"     路透哥本哈根5月13日 -    丹麦药品管理局周一表示，由于需求上升，丹麦未来几个月将面临两剂诺和诺德  减肥药Wegovy的供应短缺。丹麦药品管理局在一份声明中说，诺和诺德公司的Wegovy Flextouch 1毫克笔剂将在5月下旬至6月中旬期间出现短缺。诺和诺德公司没有立即回应置评请求。诺和诺德的 Wegovy每周注射  ，从0.25毫克活性成分semaglutide开始，逐渐增加到2.4毫克的维持剂量。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2435889374","title":"礼来下跌1.22%，报750.755美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2435889374","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2435889374?lang=zh_cn&edition=full","pubTime":"2024-05-13 22:52","pubTimestamp":1715611951,"startTime":"0","endTime":"0","summary":"5月13日，礼来(LLY)盘中下跌1.22%，截至22:52，报750.755美元/股，成交3.38亿美元。财务数据显示，截至2024年03月31日，礼来收入总额87.68亿美元，同比增长25.98%；归母净利润22.43亿美元，同比增长66.77%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2024/05/13225240629037.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2435831342","title":"BUZZ-印度西普拉公司因 25 财年利润前景良好而上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2435831342","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2435831342?lang=zh_cn&edition=full","pubTime":"2024-05-13 13:13","pubTimestamp":1715577210,"startTime":"0","endTime":"0","summary":"    5月13日 - ** 制药商Cipla  股价上涨6.5%至1425.95卢比，创2024年1月23日以来最大涨幅** 股票最后上涨 5%，在 Nifty 50 指数  中涨幅最大** InCred Equities 的分析师对 CIPL 25 财年 24.5%-25.5% 的核心利润率指导感到 \"积极的惊喜** 由于公司继续保持良好的执行力和复杂的 Gx 生产线，特别是 25 财年有 4 个多肽产品上市，因此 25 财年的评级仍有可能上调\"--Investec 分析师。** Axis Capital 表示，公司投资扩大销售队伍将帮助 Cipla 实现高于市场水平的增长，但将目标价从 1,630 卢比下调至 1,530 卢比。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2434089817","title":"礼来下跌1.21%，报762.25美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2434089817","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2434089817?lang=zh_cn&edition=full","pubTime":"2024-05-11 02:46","pubTimestamp":1715366763,"startTime":"0","endTime":"0","summary":"5月11日，礼来(LLY)盘中下跌1.21%，截至02:46，报762.25美元/股，成交8.04亿美元。财务数据显示，截至2024年03月31日，礼来收入总额87.68亿美元，同比增长25.98%；归母净利润22.43亿美元，同比增长66.77%。大事提醒：5月6日，礼来2023季度分配每1股派1.3美元股息，除权除息日2024-05-15，派息日2024-06-10。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2024/05/11024640607024.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2434862250","title":"民意调查显示，大约每 8 个美国成年人中就有 1 人服用过像维格威这样的 GLP-1 药物","url":"https://stock-news.laohu8.com/highlight/detail?id=2434862250","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2434862250?lang=zh_cn&edition=full","pubTime":"2024-05-11 01:42","pubTimestamp":1715362969,"startTime":"0","endTime":"0","summary":"    路透5月10日 - 凯撒家庭基金会周五进行的一项民意调查显示，大约八分之一的成年人服用过GLP-1类药物来减肥或治疗相关疾病。数据还显示，6%的受访者表示他们目前正在使用一种GLP-1药物，如诺和诺德的  糖尿病药物Ozempic或减肥治疗药物Wegovy，或礼来的  肥胖症药物Zepbound。在服用过 GLP-1 药物的人中，约 54% 的人认为即使有保险也很难负担得起。每十个接受调查的成年人中就有六人表示，如果处方药用于减肥，医疗保险应该支付这些药物的费用。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.lilly.com","stockEarnings":[{"period":"1week","weight":0.0132},{"period":"1month","weight":0.0256},{"period":"3month","weight":-0.0154},{"period":"6month","weight":0.3013},{"period":"1year","weight":0.7584},{"period":"ytd","weight":0.3209}],"compareEarnings":[{"period":"1week","weight":0.0165},{"period":"1month","weight":0.0577},{"period":"3month","weight":0.0599},{"period":"6month","weight":0.1745},{"period":"1year","weight":0.2629},{"period":"ytd","weight":0.1139}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"礼来公司于1901年在印第安纳州注册成立，其前身是1876年由伊利·礼来上校在印第安纳州印第安纳波利斯创立的药品生产企业。公司发现，开发，制造和销售重要医药产品。公司的宗旨是将“关爱”与“发现”结合起来，为世界各地的人们创造更美好的生活。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.011498},{"month":2,"riseRate":0.5,"avgChangeRate":-0.002909},{"month":3,"riseRate":0.613636,"avgChangeRate":0.015389},{"month":4,"riseRate":0.555556,"avgChangeRate":0.018718},{"month":5,"riseRate":0.4,"avgChangeRate":0.013484},{"month":6,"riseRate":0.590909,"avgChangeRate":0.021126},{"month":7,"riseRate":0.568182,"avgChangeRate":0.002184},{"month":8,"riseRate":0.409091,"avgChangeRate":0.00001},{"month":9,"riseRate":0.454545,"avgChangeRate":0.003204},{"month":10,"riseRate":0.590909,"avgChangeRate":0.014439},{"month":11,"riseRate":0.75,"avgChangeRate":0.027866},{"month":12,"riseRate":0.590909,"avgChangeRate":0.031834}],"exchange":"NYSE","name":"礼来","nameEN":"Eli Lilly"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"礼来(LLY)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供礼来(LLY)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"礼来,LLY,礼来股票,礼来股票老虎,礼来股票老虎国际,礼来行情,礼来股票行情,礼来股价,礼来股市,礼来股票价格,礼来股票交易,礼来股票购买,礼来股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"礼来(LLY)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供礼来(LLY)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}